Grifols, S.A.
Grifols, S.A.
GRFS
Valuace
35
Růst
23
Zdraví
80
Cena
$ 8.52
Dnes
--0.04 (-0.45%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
7.2B
Obrat
8B
Zisk
0B
Aktiva
20B
Dluh
9B
ROE
0%
ROA
0%
PE
13
PS
1
Cena 1R
6-11
⌀ Cena
9.00
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda
12-08-2025

Profil

Společnost Grifols, S.A. se zabývá pořizováním, výrobou, přípravou a prodejem léčebných přípravků, především heoderivantů. Společnost působí prostřednictvím divizí Bioscience, Hospital, Diagnostic, Bio Supplies a dalších. Divize Bioscience zkoumá, vyvíjí, vyrábí a prodává léčivé přípravky vyrobené z plazmy a další inovativní řešení pro léčbu pacientů s chronickými, vzácnými, prevalentními a život ohrožujícími onemocněními. Nabízí imunoglobuliny, alfa- 1 antitrypsin, albumin, koagulační faktory a hyperimunní globuliny. Divize Nemocnice nabízí nebiologické farmaceutické výrobky a zdravotnické potřeby pro klinickou výživu, intravenózní terapii a zdravotnické prostředky. Diagnostická divize se zabývá výzkumem, vývojem, výrobou a komercializací diagnostických produktů, které přesahují zdravotní kontinuitu_x0096_ od prevence, screeningu, diagnostiky a prognózy až po sledování onemocnění a léčby_x0096_aby sloužily odborníkům. Divize Bio Supplies poskytuje biologické materiály pro výzkum v oblasti vědy o živé přírodě, klinické zkoušky a pro výrobu farmaceutických a diagnostických produktů. Jeho produkty a služby využívají poskytovatelé zdravotní péče k diagnostice a léčbě pacientů s hemofilií, imunitním deficitem, infekčními nemocemi a dalšími zdravotními potížemi. Společnost slouží veřejným i soukromým zákazníkům, velkoobchodníkům, distributorům, skupinovým nákupním organizacím, krevním bankám, nemocnicím a pečovatelským institucím a národním zdravotnickým systémům. Grifols, S.A. má dohodu o spolupráci na technologiích s Mondragonem. Společnost byla založena v roce 1940 a sídlí ve španělské Barceloně.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
23833
Založení
2011-06-02
Adresa
Avinguda de la Generalitat, 152
CEO
Jose Ignacio Abia Buenache

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues7,505.47,227.07,212.46,592.06,064.04,933.15,340.05,098.74,486.74,318.14,049.83,934.63,355.42,741.72,620.91,795.6990.7
Cost of Revenues4,625.14,647.14,417.84,269.33,832.42,970.53,084.92,757.52,437.22,166.12,137.52,003.61,656.21,323.91,291.3466.7227.6
Gross Profit2,880.32,580.02,794.52,322.72,231.51,962.62,255.22,341.22,049.62,152.01,912.31,931.01,699.21,417.91,329.61,328.9763.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues1,963.11,865.41,891.11,785.81,975.81,793.01,817.91,625.71,769.51,597.5
Cost of Revenues1,282.71,113.91,147.31,081.21,209.31,066.21,147.5977.31,079.7965.6
Gross Profit680.4751.5743.8704.6766.5726.8670.4648.4689.8631.8
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0330.6361.1354.9294.2276.0240.7288.3197.6224.2180.8123.3124.40.00.0
Selling General & Admin Expenses0.00.00.01,254.21,190.41,061.5985.6942.8814.8860.3775.3736.4660.8558.5545.1917.9472.1
Depreciation & Amortization357.1432.2437.9441.9306.3360.3363.0358.5228.6215.5201.9189.8189.5128.5129.190.645.8
Total Operating Expenses1,607.11,392.81,602.51,584.81,529.31,400.11,279.81,218.81,055.41,148.7972.9960.6841.5681.7669.51,052.1555.0
Operating Income1,273.21,187.21,192.0737.9805.7595.1996.11,131.4994.11,003.3939.4970.4857.7736.1660.1278.9209.7
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.0113.688.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0353.2300.3
Depreciation & Amortization127.2102.815.3111.8110.1108.427.7105.6108.5107.0
Total Operating Expenses408.2368.2394.9435.8394.6409.7371.1444.6466.8388.8
Operating Income272.2383.3348.9268.9371.9317.0299.3203.8223.0250.6
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income9.632.748.162.333.911.68.0114.214.09.79.95.83.14.91.75.82.9
Interest Expense609.6600.3773.2596.9362.6233.8222.9324.4274.2249.5228.8224.6209.5215.4284.1200.633.4
Other Expense-659.3-596.5-748.0-513.9-444.4-244.6-117.5-314.311.0-54.08.2-45.6-46.0-3.510.3-1.9-5.2
IBT614.0590.7444.0224.0361.3350.5878.6817.1725.8695.7712.8690.3589.7497.5387.980.0157.8
Income Tax Expense115.1110.5231.243.390.185.1169.6168.5131.434.4168.2158.8122.6155.5132.629.842.5
Net Income401.1386.1156.959.3208.3265.3709.0625.1596.6662.7545.5532.1470.3345.6256.750.3115.5
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.09.60.00.00.014.10.0-18.50.0
Interest Expense158.5156.1141.4153.615.9197.6202.5170.091.0150.9
Other Expense-162.2-185.1-158.3-153.6-161.3-197.6-232.3-156.7-146.4-151.0
IBT110.1198.1190.5115.3210.5119.467.047.176.799.6
Income Tax Expense-14.554.752.122.8126.837.442.224.827.75.6
Net Income97.3127.0117.159.769.051.714.821.456.059.5
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$0.09$0.31$0.39$0.90$0.91$0.87$0.97$0.80$0.78$0.69$0.51$0.38$0.16$0.45
EPS Diluted$0.00$0.00$0.00$0.09$0.31$0.39$0.90$0.91$0.87$0.97$0.80$0.78$0.69$0.51$0.38$0.16$0.45
Shares Outstanding680.6680.6680.0679.1679.8681.6685.5685.1684.7684.2683.2685.3685.3681.0685.4308.0258.9
Diluted Shares Outstanding680.6680.6680.0679.1679.8681.6685.5685.1684.7684.2684.2685.7685.3681.0685.4308.0258.9
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.08$0.09
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.08$0.09
Shares Outstanding680.6680.5688.6680.4680.4679.6742.1710.6679.1678.7
Diluted Shares Outstanding680.6680.5688.6680.4680.4679.6742.1710.6679.1678.7
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents2,113.2979.8529.6548.0655.5579.6742.01,033.8886.5895.01,142.51,079.1708.8473.3340.6239.6
Short Term Investments129.524.2116.143.32,029.110.91,727.40.00.00.00.00.00.00.016.912.9
Total Cash & ST Investments2,113.21,004.0645.7591.22,684.6590.52,469.41,033.8886.5895.01,142.51,079.1708.8473.3357.5252.6
Accounts Receivable935.0741.4811.0754.8495.5504.2470.5401.6385.3528.5477.8608.3462.7447.4532.0283.0
Inventory3,623.33,560.13,459.33,201.42,259.42,002.32,342.61,949.41,629.31,642.91,431.41,194.1946.9998.61,030.3527.9
Other Current Assets243.4422.11,535.981.864.151.858.142.332.448.331.123.721.320.89.480.6
Total Current Assets6,914.95,727.56,451.94,653.65,510.33,165.05,362.23,483.32,945.33,122.53,089.52,913.12,139.71,934.61,929.21,144.1
Current Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Cash And Equivalents558.7752.8979.8644.92,113.2448.5529.6484.2523.4425.7
Short Term Investments7.1253.024.2161.8129.5160.4116.159.433.90.0
Total Cash & ST Investments565.81,005.81,004.0806.72,242.7608.9529.6543.6557.2425.7
Accounts Receivable1,252.41,039.3741.41,007.4935.1998.0810.9908.0865.7884.2
Inventory3,346.93,524.83,560.13,455.63,623.33,647.43,459.33,486.73,317.43,277.1
Other Current Assets81.170.1422.153.6113.81,504.81,652.2136.498.2121.9
Total Current Assets5,246.25,640.05,727.55,323.36,914.96,759.16,451.95,015.44,804.84,708.9
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment4,214.64,310.24,192.44,168.53,343.23,002.82,863.41,952.01,760.11,809.91,644.41,147.8840.2810.1775.9434.1
Goodwill7,102.07,403.16,802.17,011.96,228.95,332.35,507.15,209.24,590.53,644.03,532.43,174.71,829.11,869.91,895.1189.4
Intangible Assets2,880.92,926.12,832.22,949.11,637.01,557.71,433.51,385.51,269.31,195.31,161.61,068.4946.4969.11,008.378.3
Long-Term Investments704.7529.0565.12,548.92,360.02,067.2253.4228.8259.1232.478.158.739.16.06.88.1
Other Long-Term Assets142.7167.7292.127.02.10.00.0105.729.858.529.04.711.813.16.60.0
Total Long-Term Assets15,376.615,677.714,989.116,880.413,723.612,109.810,180.48,993.87,974.97,007.36,512.25,536.63,701.43,692.93,878.5744.9
Total Assets22,291.521,405.221,441.121,534.019,233.815,274.815,542.612,477.010,920.310,129.89,601.78,449.75,841.05,627.55,807.71,889.0
Long-Term Assets 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Net Property, Plant & Equipment4,036.43,241.14,310.23,162.44,214.63,250.04,192.43,278.73,225.73,220.4
Goodwill6,858.10.07,403.10.07,102.00.06,802.10.06,898.80.0
Intangible Assets2,740.611,225.22,926.110,654.42,880.910,741.12,832.20.03,748.00.0
Long-Term Investments471.0515.2529.0690.1704.7532.1702.82,597.32,536.02,576.9
Other Long-Term Assets31.9357.1167.7453.5142.7670.7154.4297.00.010,844.6
Total Long-Term Assets14,521.015,338.615,677.714,960.415,376.615,193.915,002.817,049.116,628.016,641.9
Total Assets19,767.220,978.621,405.220,283.622,291.521,953.021,454.722,064.521,432.721,350.8
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable877.7852.3813.1731.9629.0601.6581.9561.9423.1461.1410.0439.6273.6228.4280.7160.7
Short-Term Debt2,675.8639.7897.9681.32,394.2319.6320.8268.2133.1203.9186.8165.9251.4192.0147.8191.6
Other Current Liabilities507.5508.3550.9504.8407.6390.0453.2411.7407.6399.7447.0453.8182.86.2102.018.2
Current Liabilities4,112.02,156.12,315.61,955.83,474.31,335.11,366.61,257.3978.01,071.81,053.01,079.7715.3592.9646.1423.1
Current Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Accounts Payable878.70.0852.30.0877.70.0813.10.0709.00.0
Short-Term Debt394.0657.3639.71,016.92,677.71,745.3897.9757.2655.2761.3
Other Current Liabilities631.41,512.9508.31,338.7505.51,293.1550.91,267.8483.91,280.0
Current Liabilities1,990.22,170.22,156.12,355.64,112.03,038.42,315.62,025.11,877.02,041.3
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt6,938.59,446.09,219.59,068.96,930.16,591.86,786.16,020.55,878.24,681.14,571.84,071.62,438.02,586.02,809.2665.4
Capital Leases1,025.41,141.41,111.31,016.9873.7733.5740.712.99.49.911.517.519.224.60.08.0
Def. Tax Liability991.01,011.7988.61,034.8634.0556.8463.8404.4388.9600.6631.6538.8454.1453.8538.479.1
Total Liabilities13,982.312,798.213,468.613,076.411,086.88,554.78,696.87,780.47,286.36,401.86,300.35,786.93,733.83,746.74,142.71,181.6
Long-Term Liabilities 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Long-Term Debt8,425.59,389.99,446.08,836.37,963.89,650.49,219.510,299.49,373.09,998.6
Capital Leases1,089.50.01,141.41.11,134.20.01,004.20.0890.50.0
Def. Tax Liability922.30.01,011.70.0991.00.01,002.20.01,002.90.0
Total Liabilities12,169.012,684.712,798.212,288.613,982.313,831.213,468.413,495.813,209.213,175.6
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock119.6119.6119.61,030.31,030.31,030.31,030.31,030.31,030.31,030.31,030.31,030.31,030.31,008.2117.90.0
Retained Earnings36.3205.759.3208.3182.8618.5488.3459.9539.7422.5412.5384.3276.8256.750.3115.5
Comprehensive Income4,707.74,782.24,890.35,053.55,047.73,503.23,353.12,790.82,121.52,337.31,911.91,312.7794.1614.9627.1352.9
Total Common Equity5,592.75,883.75,827.26,129.96,096.65,108.44,822.14,225.63,629.13,721.53,296.22,658.12,101.31,876.81,662.5693.0
Total Common Equity 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Common Stock119.6119.6119.6119.6119.6119.6119.6119.61,030.3119.6
Retained Earnings176.859.7205.788.036.321.459.33.3-56.20.0
Comprehensive Income4,094.14,681.64,782.24,376.94,671.45,044.74,949.65,252.15,046.44,984.7
Total Common Equity5,169.15,639.55,883.75,349.95,592.75,943.75,827.26,127.15,861.85,852.8
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt10,639.610,085.610,117.49,750.19,324.36,911.47,106.96,288.76,011.24,885.04,758.64,237.42,689.42,778.02,957.0857.0
Book Value8,309.18,607.07,972.58,457.58,147.06,720.16,845.84,696.63,634.03,728.03,301.42,662.92,107.21,880.71,665.0707.4
Other 2-20251-20254-20243-20242-20241-20244-20233-20232-20231-2023
Total Debt2,429.12,654.42,723.32,645.22,702.62,178.12,145.32,441.62,361.72,322.4
Book Value5,169.15,639.55,883.75,349.95,592.75,943.75,827.26,127.15,861.85,852.8
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income151.8386.1444.059.3361.3350.5878.6817.1725.8695.7712.8690.3589.7497.5387.980.0157.8
Depreciation & Amortization434.9432.2437.9441.9407.9359.8321.5302.5228.6215.5201.9189.8189.5128.5129.190.645.8
Stock-Based Compensation0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Change Working Capital-232.8-24.022.4-369.6-609.2-140.9106.3-481.5-112.6-65.8-164.3-77.195.340.3-43.6-51.3-78.8
Change In Accounts Receivable-33.5-30.7-41.9-53.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Change In Accounts Payable152.090.30.0103.30.00.00.00.00.00.00.00.00.00.00.00.00.0
Change In Inventories-361.8-93.225.8-427.1-600.2-157.5164.6-323.7-231.7-165.5-173.0-120.6-97.017.314.56.9-18.3
Other Non-cash Items485.0211.3-2.176.7-170.827.7-196.1-69.1-104.4-3.7-197.0-60.2104.5-74.333.7100.8-20.5
Cash from Operations400.00.00.0208.3-10.9597.01,110.3568.9737.4841.7553.3742.8978.9592.0507.1220.2104.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income97.3127.0117.159.769.051.714.821.456.059.5
Depreciation & Amortization127.2102.8107.0111.8110.1108.4113.8105.6108.5107.0
Stock-Based Compensation0.00.00.00.00.00.00.00.00.00.0
Change Working Capital163.6-39.6-97.3-154.2176.7-22.963.4-283.845.3-57.8
Change In Accounts Receivable95.2-13.3-77.8-93.367.3-19.551.3-153.7-4.673.4
Change In Accounts Payable39.40.00.00.00.0-62.30.00.0126.325.7
Change In Inventories19.3-26.3-30.6-60.899.858.9-2.8-130.1-88.4-140.4
Other Non-cash Items30.5135.228.5118.2158.8162.560.8-8.2-53.5302.1
Cash from Operations0.00.00.00.00.00.00.00.0156.4155.6
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-237.9-406.3-232.5-209.5-375.6-315.1-362.6-412.3-307.7-323.0-292.7-567.0-287.0-172.8-166.1-159.9-103.4
Acquisitions-165.9-99.9-285.9-24.0-1,441.9326.0-468.6-119.7-524.1-1,857.2-202.7-58.6-1,235.0-69.2-9.2-1,624.9-1.5
Investments-70.4-54.8-43.9-93.3-164.7-42.5-27.2-19.4-20.7-29.5-13.7-21.8-13.5-10.820.122.7-12.7
Sales of Investment1.84.80.015.10.01.582.4101.970.123.043.314.351.116.831.05.80.6
Other Investing Activities1,469.00.00.0-85.93.30.6-82.1-99.20.60.8-40.80.0-36.70.059.8137.612.9
Cash from Investing996.60.00.0-397.6-1,978.8-29.4-858.1-548.8-781.9-2,185.9-506.7-633.1-1,521.1-236.0-64.4-1,618.7-104.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-130.8-70.1-60.2-49.1-100.1-84.2-30.5-38.1-103.1-66.2
Acquisitions-2.30.0-5.2-97.0-1,596.7-114.4-118.9-20.224.7-51.5
Investments-55.00.00.00.00.00.00.00.0-93.322.9
Sales of Investment4.80.00.00.00.00.00.00.015.1-13.4
Other Investing Activities0.00.00.00.00.00.00.00.014.7-14.7
Cash from Investing0.00.00.00.00.00.00.00.0-141.9-122.9
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-2,223.80.00.0-105.9-104.3-82.7-351.9-127.6-141.9-103.8-161.7-149.7-3,970.8-132.9-281.3-1,232.2-119.3
Debt Issued1,927.510,085.6-31.8473.2530.12,495.6156.4945.8419.41,230.0288.1670.95,518.944.3102.33,332.2976.3
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.00.971.23,970.8155.75.20.0118.2
Repurchase of Common Stock0.0-123.90.00.0-3.5-125.70.00.00.00.0-12.7-58.5-69.3-120.4-5.2-2.8-1.3
Dividends Paid0.00.00.00.0-0.6-258.9-113.2-238.7-278.8-218.3-216.2-221.8-156.0-69.1-281.30.0-27.3
Other Financing Activities-1,711.60.00.0291.9-65.21,940.3110.734.0573.31,756.260.0200.81,066.461.7257.32,710.00.3
Cash from Financing192.00.00.0186.0-173.51,472.9-354.4-332.4152.51,434.1-329.6-158.0841.1-105.1-305.31,475.0-29.3
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.0-82.0
Debt Issued0.08,819.4-1,227.7-38.4232.5-788.4-754.21,278.3-939.3202.8
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-124.40.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.046.52.6
Cash from Financing0.00.00.00.00.00.00.00.046.5-79.4
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash1,589.9-38.8450.2-18.4-2,127.62,096.0-162.3-291.8147.3-8.5-247.563.4370.4235.5132.7100.9-9.7
Closing Cash Balance2,113.2824.6979.8529.6548.02,675.6579.6742.01,033.8886.5895.01,142.51,079.1708.8473.3340.6239.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash203.762.3-194.1-227.0334.8-1,468.31,664.7-81.032.9-39.1
Closing Cash Balance824.6621.0558.7752.8979.8644.92,113.2448.5529.6484.2
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow162.1751.1530.8-87.1-386.4281.9747.8156.6429.7518.8260.6175.8691.9419.2341.060.30.9
Real Free Cash Flow162.1751.1530.8-87.1-386.4281.9747.8156.6429.7518.8260.6175.8691.9419.2341.060.30.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow335.2255.495.086.3414.5215.4222.4-203.053.389.4
Real Free Cash Flow335.2255.495.086.3414.5215.4222.4-203.053.389.4
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E12.928.386.1
P/S0.72.6578
P/B0.77.7582.9
P/FCF6.7-3.910581.1
Market cap$7.2$7.1
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %39 %0 %
Debt to Income2198.9 %1568.7 %0 %
Debt to Free cash flow1142.6 %19.3 %0 %
Interest expense percentage47.9 %21.2 %7 %
Current ratio2.6 2.5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE7.8 %10.6 %0 %
ROA2 %6.1 %0 %
CapEx to Revenue3.7 %7 %10.5 %
RaD to Revenue0 %3.7 %0 %
ROEM3,752,708.6 1971117.1

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin39.5 %47.6 %77.7 %
Operating margin18.3 %23.1 %29.4 %
Net margin5 %9.9 %22.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.7 %0 %
Dividend payout percentage0 %18 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding680.5 mil 666.6 mil
Employee count2.0 tis 1.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader